HM Payson & Co’s Zai Lab ZLAB Stock Holding History

HM Payson & Co’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-567	Closed	-$76K	–	1188
2021 Q1	$76K	Hold	567	–	–	﹤0.01%	529
2020 Q4	$77K	Sell	567 -133	-19%	-$13.5K	﹤0.01%	522
2020 Q3	$58K	Buy	+700	New	+$56.2K	﹤0.01%	537

Other funds holding ZLAB

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BAM

Brilliance Asset Management Admiralty, Hong Kong, Hong Kong $339M AUM 9.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

HM Payson & Co's ZLAB Position: Q2 2021 in Review

HM Payson & Co sold out of Zai Lab (ZLAB) in Q2 2021, closing a stake of 567 shares — an estimated $76K sold.

HM Payson & Co first reported a position in ZLAB in Q3 2020 and held it in 3 quarters. The position peaked at $77K in Q4 2020. 233 funds tracked by Wall St. Rank hold ZLAB as of Q2 2021.

HM Payson & Co reported no remaining Zai Lab position as of Q2 2021 after selling out during the quarter.
HM Payson & Co sold 567 Zai Lab shares in Q2 2021, an estimated $76K.
HM Payson & Co first reported a position in Zai Lab in Q3 2020 and held it in 3 quarters.
HM Payson & Co's Zai Lab position peaked at $77K in Q4 2020.
233 funds tracked by Wall St. Rank held Zai Lab as of Q2 2021.

Based on HM Payson & Co's 13F filing for Q2 2021, filed 17 Aug 2021.